Adaptive Biotechnologies, the heavily-funded Seattle bioinformatics company, today announced that Diego Miralles will become the president of a new division of… Read More
The University of Washington held its first annual Health Innovation Challenge (HIC) Thursday—bringing innovators in entrepreneurship, business and health science… Read More
The Washington state legislature is looking at reviving two expired high-tech research-and development tax breaks — minus the previous exemptions… Read More
Nohla Therapeutics just became the latest biotech startup to come out of the Fred Hutchinson Cancer Research Center. Like spinouts before it, Nohla is already… Read More
Arivale, the “scientific wellness” startup co-founded by genomics pioneer Lee Hood, has hired Grant Ries, the co-founder of big-data company BlueKai,… Read More
Shares of Seattle-based biotech startup Juno Therapeutics spiked more than 60 percent in after-hours trading on Monday after the company announced… Read More
Five years after coming to Seattle via its purchase of ZymoGenetics, drug giant Bristol-Myers Squibb is moving 40 Seattle-based research and… Read More
The intersection of major research outposts like Fred Hutchinson Cancer Research Center and the University of Washington, plus a thriving tech… Read More
Shares of Seattle Genetics stumbled on Tuesday after the Bothell-based company announced a partnership to license the Antibody-Coupled T-cell Receptor… Read More
The Fred Hutchinson Cancer Research Center helped spark a number of groundbreaking spin-off companies in recent years, from publicly-traded Juno… Read More
—Telecommunications entrepreneur Vern Fotheringham has been named CEO of Leosat, an Arlington, Virginia-based company developing a constellation of low-earth orbit… Read More
Dendreon, the once-promising Seattle biotechnology company that developed treatments for prostate cancer, will be sold to Quebec-based Valeant Pharmaceuticals International Inc.… Read More
Juno Therapeutics, the fast-growing Seattle biotechnology company, today announced that it plans to open a new manufacturing facility in Bothell… Read More
Adaptive Biotechnologies, a Seattle company that’s working on sequencing to profile T-cell and B-cell receptors, today announced that it is acquiring… Read More
Cerevast Therapeutics, a 5-year-old Redmond company that’s developing a novel approach for treating stroke patients with ultrasound, has raised $10 million… Read More
Don't miss a headline!
Sign up for GeekWire's newsletters today.
Thanks for subscribing!
Check your inbox to confirm your subscription.
